Lauret E, Dumenil D, Miyanomae T, Sainteny F
Cellular Kinetics Research Unit, INSERM U.250, Gustave-Roussy Institute, Villejuif, France.
Exp Hematol. 1989 Dec;17(11):1081-5.
Because the molecular mechanisms of the tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (AcSDKP; an inhibitor of spleen colony-forming unit [CFU-S] DNA synthesis) are difficult to study on bone marrow due to the scarcity of CFU-S in this tissue, we sought a pure cell population responsive to the molecule in vitro. Although growth factor-stimulated DNA synthesis in primary culture of hepatocytes and Balb/c 3T3 cells can be inhibited by transforming growth factor beta (TGF beta) and interferon alpha/beta (IFN[alpha/beta], respectively, neither hepatocytes nor 3T3 cells were found to be sensitive to AcSDKP. DNA synthesis in stimulated murine FDC-P2 cell lines and in human K562 cell lines also remained unchanged after exposure to the tetrapeptide. The fact that hepatocytes do respond in vivo to AcSDKP implies the existence of intermediary cell(s) involved in AcSDKP action in vivo that are lacking in hepatocyte culture. Whether intermediary cell(s) are implicated in the inhibitory action of AcSDKP on CFU-S entry into DNA synthesis is now being investigated.
由于在骨髓中脾集落形成单位(CFU-S)数量稀少,使得四肽乙酰-N-丝氨酸-天冬氨酸-赖氨酸-脯氨酸(AcSDKP;一种抑制CFU-S DNA合成的物质)的分子机制难以在骨髓中进行研究,因此我们试图寻找一种在体外对该分子有反应的纯细胞群体。尽管肝细胞原代培养物和Balb/c 3T3细胞中生长因子刺激的DNA合成可分别被转化生长因子β(TGFβ)和干扰素α/β(IFN[α/β])抑制,但未发现肝细胞和3T3细胞对AcSDKP敏感。在刺激的小鼠FDC-P2细胞系和人K562细胞系中,暴露于该四肽后DNA合成也保持不变。肝细胞在体内确实对AcSDKP有反应,这一事实表明在体内参与AcSDKP作用的中间细胞在肝细胞培养中并不存在。目前正在研究中间细胞是否与AcSDKP对CFU-S进入DNA合成的抑制作用有关。